(CDIV) Manulife Smart Dividend - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Etf • ISIN: CA56502U1084

Dividend, Income, Equity, Stocks, Investments

Description: CDIV Manulife Smart Dividend

The Manulife Smart Dividend ETF (CDIV) is a Canadian equity exchange-traded fund that focuses on dividend-paying stocks, aiming to provide investors with a regular income stream. As a dividend-centric ETF, it is designed to track the Morningstar Canada GR CAD Index, which comprises a diversified portfolio of Canadian dividend-paying equities.

By leveraging the expertise of Manulife Investment Management, the fund is managed to optimize returns while minimizing risk. The ETFs investment strategy is centered around selecting high-quality dividend-paying stocks, which are typically characterized by their stability, financial health, and ability to sustain dividend payments over time.

Analyzing the funds technical data, we observe that CDIV has demonstrated a strong upward trend, with its last price of $16.00 exceeding both its 20-day and 50-day simple moving averages (SMA20: $15.99, SMA50: $15.49). This indicates a positive momentum, suggesting that the ETF is likely to continue its upward trajectory. Furthermore, the Average True Range (ATR) of 0.09 (0.56%) implies relatively low volatility, making it an attractive option for risk-averse investors seeking stable returns.

From a fundamental perspective, the funds Assets Under Management (AUM) stand at $644.28 million CAD, indicating a moderate level of investor interest. As the ETF continues to grow, it is likely to attract more investors seeking exposure to Canadian dividend-paying stocks.

Based on the technical and fundamental data, our forecast suggests that CDIV is poised for further growth, potentially reaching $17.00 in the near term. This projection is supported by the ETFs strong momentum, low volatility, and the overall attractiveness of dividend-paying stocks in the current market environment. As the fund continues to track the Morningstar Canada GR CAD Index, we expect it to maintain its position as a reliable source of dividend income for investors.

Additional Sources for CDIV ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CDIV ETF Overview

Market Cap in USD 512m
Category Canadian Dividend and Income Equity
IPO / Inception 2020-11-25

CDIV ETF Ratings

Growth Rating 78.3
Fundamental -
Dividend Rating 60.6
Rel. Strength 3.49
Analysts -
Fair Price Momentum 17.20 CAD
Fair Price DCF -

CDIV Dividends

Dividend Yield 12m 2.75%
Yield on Cost 5y 4.78%
Annual Growth 5y 135.12%
Payout Consistency 81.4%
Payout Ratio %

CDIV Growth Ratios

Growth Correlation 3m 98.2%
Growth Correlation 12m 73.7%
Growth Correlation 5y 89.9%
CAGR 5y 13.84%
CAGR/Max DD 5y 0.84
Sharpe Ratio 12m 2.52
Alpha 10.67
Beta 0.444
Volatility 8.31%
Current Volume 10k
Average Volume 20d 9.2k
Stop Loss 15.8 (-2.8%)
What is the price of CDIV shares?
As of July 19, 2025, the stock is trading at CAD 16.26 with a total of 9,998 shares traded.
Over the past week, the price has changed by +0.12%, over one month by +1.67%, over three months by +11.85% and over the past year by +19.31%.
Is Manulife Smart Dividend a good stock to buy?
Yes. Based on ValueRay's Analyses, Manulife Smart Dividend (TO:CDIV) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 78.26 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CDIV is around 17.20 CAD . This means that CDIV is currently overvalued and has a potential downside of 5.78%.
Is CDIV a buy, sell or hold?
Manulife Smart Dividend has no consensus analysts rating.
What are the forecasts for CDIV share price target?
According to our own proprietary Forecast Model, CDIV Manulife Smart Dividend will be worth about 19.2 in July 2026. The stock is currently trading at 16.26. This means that the stock has a potential upside of +18.2%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 19.2 18.2%